Immunosuppressive effect of budesonide on human lamina propria lymphocytes (Q45295744)

11 December 2017

title

Immunosuppressive effect of budesonide on human lamina propria lymphocytes (English)

1 reference

11 December 2017

Elitsur Y

1

1 reference

11 December 2017

Lichtman SN

2

1 reference

11 December 2017

Neace C

3

1 reference

11 December 2017

Dosescu J

4

1 reference

11 December 2017

Moshier JA

5

1 reference

11 December 2017

publication date

1 January 1998

1 reference

11 December 2017

1 reference

11 December 2017

volume

38

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

279-285

1 reference

A microprocedure for the measurement of 14CO2 release from [14C]carboxyl-labeled amino acids

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Isolation and functional characterization of human intestinal mucosal lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Use of budesonide in severe asthmatics aged 1-3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Modulation of human colonic lamina propria lymphocyte proliferation. Effect of bile acids and oxidized fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Inhibition of ornithine decarboxylase activity decreases polyamines and suppresses DNA synthesis in human colonic lamina propria lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Pharmacology of 11 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Immunogenetics of cytokines. Relevance for future research on inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Effects of "systemic" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

A comparison of budesonide with prednisolone for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Rapid activation of ornithine decarboxylase by mitogenic (but not by nonmitogenic) ligands in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Corticosteroids class-dependently inhibit in vitro Th1- and Th2-type cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Relationship between lung tissue and blood plasma concentrations of inhaled budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900090-8

7 January 2021

10.1016/S0162-3109(97)00090-8

Identifiers

DOI

1 reference

11 December 2017

1 reference